HCA Healthcare, Inc. is set to announce its fiscal Q4 earnings for 2025. Analysts anticipate a profit of $7.37 per share, up 18.5% from last year. For the current fiscal year, profit is expected to rise to $27.60 per share, a 25.7% increase from 2024. EPS is projected to grow to $29.66 in 2026.

Shares of HCA have surged 55.5% over the past year, outperforming the S&P 500 and XLV. After exceeding Q3 earnings expectations, HCA raised its fiscal 2025 guidance with revenue expected to be between $75 billion to $76.5 billion, and EPS between $27 and $28.

Analysts have a “Moderate Buy” rating on HCA stock. The mean price target is $486.41, indicating a 3% potential upside from current levels. Wall Street predicts strong performance for HCA, with 14 analysts recommending a “Strong Buy” rating, one suggesting a “Moderate Buy,” and nine advising to “Hold.”

Read more at Yahoo Finance: What to Expect From HCA Healthcare’s Next Quarterly Earnings Report